18F-MFBG PET/CT检出儿童高危神经母细胞瘤孤立性多发软脑膜转移
本文报告1例2岁高危神经母细胞瘤女童:基线18F-MFBG PET/CT显示腹部原发灶并多发转移,诱导治疗后复查未见异常摄取;6个月随访时18F-MFBG PET/CT显示颅内部仅有多发18F-MFBG高摄取灶、颅外无复发,随后增强脑MRI证实软脑膜转移。提示18F-MFBG PET/CT可检出孤立性多发软脑膜转移,可用于儿童神经母细胞瘤中枢神经系统受累监测。
要点
- 18F-MFBG PET/CT可在颅外无复发时显示颅内部多发高摄取灶
- 该显像阳性发现经增强脑MRI证实为软脑膜转移
- 提示18F-MFBG PET/CT可用于儿童神经母细胞瘤中枢受累监测
核心结论
- 18F-MFBG PET/CT可检出儿童高危神经母细胞瘤的孤立性多发软脑膜转移,支持其用于中枢神经系统受累监测。
研究设计与样本
- 个案报道:1例2岁高危神经母细胞瘤女童,行基线、诱导治疗后及6个月随访18F-MFBG PET/CT,并以增强脑MRI验证。
主要发现
- 基线18F-MFBG PET/CT示腹部原发灶并多发转移,诱导治疗后复查未见异常18F-MFBG摄取。
- 6个月随访18F-MFBG PET/CT示多发18F-MFBG高摄取病灶仅局限于颅内部,无颅外复发证据。
- 后续增强脑MRI证实软脑膜转移。
临床怎么用
- 对高危神经母细胞瘤患儿,可在随访中以18F-MFBG PET/CT监测中枢神经系统受累,发现颅内部高摄取灶时结合增强脑MRI确认。
局限性
- 仅为单例个案报道,结论的外推需更多病例验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 2-year-old girl was diagnosed with high-risk neuroblastoma. Baseline 18F-MFBG PET/CT demonstrated primary abdominal disease with concurrent multiple metastases. Following induction therapy, restaging 18F-MFBG PET/CT did not show any abnormal 18F-MFBG uptake. However, at six-month follow-up, repeat 18F-MFBG PET/CT revealed multifocal 18F-MFBG-avid lesions confined exclusively to the cranial compartment, with no evidence of extracranial disease recurrence. Subsequent contrast-enhanced brain MRI confirmed the presence of leptomeningeal metastases. This case illustrates that isolated multifocal leptomeningeal metastases may be reliably detected on 18F-MFBG PET/CT, underscoring the utility of this modality in the surveillance of central nervous system involvement in pediatric patients with neuroblastoma.
引用
- Shi Z, Zheng L, Zhang K, et al. Detecting Isolated Multifocal Leptomeningeal Metastases With 18F-MFBG PET/CT in a Pediatric Patient With High-risk Neuroblastoma. Clin Nucl Med. 2026. PMID: 42912542. doi:10.1097/RLU.0000000000006683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。